significant shortened recovery time significant benefit investigators decided stop trial early ethical reasons said ensure participants receiving placebo access drug fauci added remdesivir standard treatment covid-19 news comes weeks data leaks day mixed results clinical trials drug trial run drug maker gilead sciences foster city california half 400 participants severe covid-19 recovered illness weeks receiving treatment study lacked placebo controlled arm making results difficult interpret smaller trial run china found benefits remdesivir compared placebo trial stopped early difficulty enroling participants outbreak subsided china onlookers hopeful large niaid trial provides glimmer hope race find drug works coronavirus infected 3 million people